IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 158 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,040,800 | +77.1% | 159,632 | +136.6% | 0.00% | – |
| Q1 2024 | $587,768 | -82.7% | 67,482 | -77.3% | 0.00% | -100.0% |
| Q4 2023 | $3,396,662 | -31.4% | 296,911 | -42.3% | 0.00% | -50.0% |
| Q3 2023 | $4,954,606 | +104.7% | 514,497 | +126.1% | 0.00% | +100.0% |
| Q2 2023 | $2,420,749 | -88.1% | 227,514 | -88.2% | 0.00% | -87.5% |
| Q1 2023 | $20,260,279 | +1047.2% | 1,925,882 | +1251.1% | 0.01% | +700.0% |
| Q4 2022 | $1,766,071 | +224.0% | 142,540 | +170.8% | 0.00% | – |
| Q3 2022 | $545,000 | -80.5% | 52,633 | -78.3% | 0.00% | -100.0% |
| Q2 2022 | $2,791,000 | +99.5% | 242,028 | +117.7% | 0.00% | – |
| Q1 2022 | $1,399,000 | -46.9% | 111,155 | -50.9% | 0.00% | – |
| Q4 2021 | $2,637,000 | -49.6% | 226,157 | -43.5% | 0.00% | -100.0% |
| Q3 2021 | $5,228,000 | +70.1% | 400,301 | +67.7% | 0.00% | +100.0% |
| Q2 2021 | $3,073,000 | +90.9% | 238,701 | +65.8% | 0.00% | – |
| Q1 2021 | $1,610,000 | +70.7% | 143,942 | +73.9% | 0.00% | – |
| Q4 2020 | $943,000 | -6.1% | 82,789 | -25.8% | 0.00% | – |
| Q3 2020 | $1,004,000 | +208.0% | 111,649 | +253.5% | 0.00% | – |
| Q2 2020 | $326,000 | +98.8% | 31,584 | +65.1% | 0.00% | – |
| Q3 2019 | $164,000 | -78.3% | 19,125 | -73.8% | 0.00% | -100.0% |
| Q4 2018 | $757,000 | +320.6% | 73,073 | +526.2% | 0.00% | – |
| Q1 2018 | $180,000 | -32.6% | 11,670 | -34.4% | 0.00% | -100.0% |
| Q4 2017 | $267,000 | -16.8% | 17,788 | -12.7% | 0.00% | 0.0% |
| Q3 2017 | $321,000 | -43.6% | 20,383 | -32.4% | 0.00% | -50.0% |
| Q2 2017 | $569,000 | +193.3% | 30,150 | +165.4% | 0.00% | +100.0% |
| Q1 2017 | $194,000 | -11.0% | 11,362 | -17.4% | 0.00% | 0.0% |
| Q3 2016 | $218,000 | +56.8% | 13,754 | +8.0% | 0.00% | 0.0% |
| Q1 2016 | $139,000 | -34.4% | 12,733 | -22.2% | 0.00% | -50.0% |
| Q3 2014 | $212,000 | -78.9% | 16,365 | -75.1% | 0.00% | -84.6% |
| Q2 2014 | $1,007,000 | – | 65,658 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 3,367,100 | $62,156,000 | 13.71% |
| EcoR1 Capital, LLC | 5,141,624 | $94,914,000 | 8.55% |
| Broderick Brian C | 329,233 | $6,078,000 | 2.06% |
| Penn Capital Management Company, LLC | 764,028 | $17,466,000 | 1.33% |
| Brown Capital Management | 6,449,511 | $119,058,000 | 1.08% |
| Park West Asset Management LLC | 1,194,945 | $22,059,000 | 0.80% |
| BRIDGER MANAGEMENT, LLC | 621,891 | $11,480,000 | 0.66% |
| Orbimed Advisors | 2,929,250 | $54,074,000 | 0.65% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 103,840 | $1,917,000 | 0.60% |
| SYMPHONY ASSET MANAGEMENT LLC | 113,100 | $2,088,000 | 0.56% |